Loading [a11y]/accessibility-menu.js
A Comparison of Methodologies for Pulmonary Veins Segmentation in High Definition Voltage Maps of Patients with Atrial Fibrillation | IEEE Conference Publication | IEEE Xplore

A Comparison of Methodologies for Pulmonary Veins Segmentation in High Definition Voltage Maps of Patients with Atrial Fibrillation


Abstract:

This paper compares three methodologies used to segment images extracted from the atria of patients with atrial fibrillation (AF). We collected voltage maps of 120 patien...Show More

Abstract:

This paper compares three methodologies used to segment images extracted from the atria of patients with atrial fibrillation (AF). We collected voltage maps of 120 patients' left atrium before being treated for AF with tissue ablation. The high-definition voltage maps (HDVM) were extracted with the Rythmia software system from Boston Scientific and subsequently analyzed offline in MATLAB. During the analysis, the atrium is segmented into three main structures: body, pulmonary veins (PVs), and mitral valve (MV). Method I is based on a manual elimination of the PV by the operator. Method II uses a semi-automatic method based on geometric considerations coupled with a threshold for voltage value. Method III, in addition, uses geometric features, i.e., the geometric curvature, to eliminate the maps' PVs. We quantitatively compare the two first methods' efficiency and ease of use. In particular, the values of two electrical biomarkers associated with the maps are computed before and after the PV's elimination process. This allows us to classify them according to their sensitivity with respect to the cleaning of the PVs. Finally, we discuss which methodology is more adequate to perform the PVs and MV segmentation in light of improving the precision of the resulting maps.
Date of Conference: 01-04 October 2023
Date Added to IEEE Xplore: 26 December 2023
ISBN Information:

ISSN Information:

Conference Location: Atlanta, GA, USA

1. Introduction

The field of medical technology is experiencing a revolution towards the objective of “personalized medicine”. Cardiovascular diseases are the leading cause of death and are a medical research priority in the European Union (EU).

Contact IEEE to Subscribe

References

References is not available for this document.